Implantable cardioverter defibrillator (ICD) testing during the implan
tation process is important in order to avoid repeated induction of ar
rhythmias, which extends the implantation procedure and poses a risk t
o the patient. Hence, an in vitro testing system has been designed to
assist optimal device programming and avoid repetitive inductions. The
system includes a high-speed computer with A/D and D/A subsystems. So
ftware has been designed to eliminate repeated arrhythmia induction by
real-time capture and storage of the electrogram. Subsequently, the e
lectrogram can be replayed into ICD software simulators at a variety o
f settings to determine candidate programming parameters. To validate
the simulation system, signals were fed directly to an ICD via an atte
nuator. Output event markers were captured simultaneously with the sig
nal into a digital file to assess the device performance. Four ventric
ular tachycardia (VT), three supraventricular tachycardia, (SVT), thre
e atrial flutter (AFL), three atrial fibrillation (AF), anti ten ventr
icular fibrillation (VF) passages were used to verify the system. Test
settings were 110-160 beats/min for detection rate and 5 seconds for
shock delay. The simulator and ICD detected the episodes for all passa
ges at the 110 beats/min setting. For the setting of 160 beats/mir, tw
o VTs, two SVTs, three AFLs, and nine VFs were detected by the device,
but no Afb triggered a shock. The simulator detection criteria were m
et by two VTs, two SVTs, three AFLs, ten VFs, and one AE. The mean det
ection time was 6,869-7,330 ms (110-160 beats/min) for the simulator a
nd 7,840-8,170 ms for device. Comparison of results showed general agr
eement between simulator and device. Results demonstrated that device
behavior at a variety of settings can he elucidated by the simulator f
or selection of optimal performance. The automated system can also fun
ction as a test bed for evaluation of new algorithms during device dev
elopment and design.